Penserra Capital Management’s MediciNova MNOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,120
Closed -$4K 1477
2021
Q3
$4K Buy
1,120
+10
+0.9% +$38 ﹤0.01% 1421
2021
Q2
$4K Buy
1,110
+5
+0.5% +$22 ﹤0.01% 1322
2021
Q1
$5K Buy
1,105
+75
+7% +$436 ﹤0.01% 1087
2020
Q4
$5K Buy
+1,030
New +$5.9K ﹤0.01% 987

Other funds holding MNOV

Penserra Capital Management's MNOV Position: Q4 2021 in Review

Penserra Capital Management sold out of MediciNova (MNOV) in Q4 2021, closing a stake of 1,120 shares — an estimated $4K sold.

Penserra Capital Management first reported a position in MNOV in Q4 2020 and held it in 4 quarters. The position peaked at $5K in Q1 2021. 42 funds tracked by Wall St. Rank hold MNOV as of Q4 2021.

  • Penserra Capital Management reported no remaining MediciNova position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 1,120 MediciNova shares in Q4 2021, an estimated $4K.
  • Penserra Capital Management first reported a position in MediciNova in Q4 2020 and held it in 4 quarters.
  • Penserra Capital Management's MediciNova position peaked at $5K in Q1 2021.
  • 42 funds tracked by Wall St. Rank held MediciNova as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.